IMMUNOME INC (IMNM) Stock News

USA - Nasdaq - NASDAQ:IMNM - US45257U1088 - Common Stock

21.18 USD

-2.3 (-9.8%)

Last: 12/17/2025, 12:21:08 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

IMNM Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill - Mentions: IRBT HAIN RRGB NCI ...

News Image

Which stocks are gapping on Monday?

16 hours ago - By: Immunome, Inc.

Immunome Announces Pricing of Public Offering of Common Stock

a day ago - By: Equity Insider - Mentions: ONCY PRLD CNTX RLAY

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards

2 days ago - By: The Motley Fool

Why Immunome Stock Surged Today

2 days ago - By: Immunome, Inc.

Immunome Announces Proposed Public Offering of Common Stock

2 days ago - By: Stocktwits

Why Is IMNM Stock Rising Today?

2 days ago - By: Immunome, Inc.

Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

3 days ago - By: Immunome, Inc.

Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

13 days ago - By: Immunome, Inc.

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

22 days ago - By: Immunome, Inc.

Immunome to Present at Upcoming Investor Conferences

a month ago - By: Immunome, Inc.

Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update

a month ago - By: Immunome, Inc.

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Immunome, Inc.

Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference

2 months ago - By: Immunome, Inc.

Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

3 months ago - By: Immunome, Inc.

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Benzinga

Where Immunome Stands With Analysts

3 months ago - By: Infinimmune

Infinimmune Announces Research Collaboration with Immunome

3 months ago - By: Benzinga

Where Immunome Stands With Analysts

3 months ago - By: Stocktwits - Mentions: IWMW VTWG

News Image

Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’

3 months ago - By: Immunome, Inc.

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Immunome, Inc.

Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference

4 months ago - By: Zacks Investment Research - Mentions: DTIL

Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates

4 months ago - By: The Motley Fool

Immunome (IMNM) Q2 Revenue Surges 382%

4 months ago - By: Zacks Investment Research - Mentions: VYGR

Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates

4 months ago - By: Immunome, Inc.

Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Zacks Investment Research - Mentions: JAZZ

Jazz Pharmaceuticals (JAZZ) Reports Q2 Loss, Misses Revenue Estimates

5 months ago - By: Immunome, Inc.

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Immunome, Inc.

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Immunome, Inc.

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)